Ebos Group Limited
Ebos Group Limited
- P/E ratio
- 16.74
Your view on EBO.AX
Overview
What the company does, where it operates, and who runs it.
About Ebos Group Limited
- Industry
- Medical - Distribution
- Sector
- Healthcare
- CEO
- Adam Luke Hall
- Headquarters
- 737 Bourke Street, Docklands, VIC, AU
- Industry
- Medical - Distribution
- Sector
- Healthcare
- CEO
- Adam Luke Hall
- Headquarters
- 737 Bourke Street, Docklands, VIC, AU
EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, and animal care products in Australia, Southeast Asia, and New Zealand. It operates through Healthcare and Animal Care segments.
The company provides healthcare logistics; medication management solutions; pharmacy management software; loyalty, generics, compliance, business intelligence, and store software services; and health communications, programs, and consultancy services.
It also offers community based health care services and programs; vitamins, minerals and supplements, herbal and fruit teas, and natural toothpastes, as well as functional foods, including molasses and manuka honey; Pharmacy Choice, a five step integrated retail program for independent pharmacies; and healthSAVE, a community pharmacy banner that helps members drive their retail businesses.
Further, it offers healthcare distribution, warehousing, clinical trial management, and product registration services; clinical trial logistics; aesthetic healthcare devices, medical-grade cosmeceuticals, and injectables; and surgical devices and medical consumables.
Additionally, the company provides pet nutrition, treats, clean-up, and grooming products and accessories; and wholesales veterinary products. The company was formerly known as Early Bros Dental & Surgical Supplies Ltd. and changed its name to EBOS Group Limited in 1986.
EBOS Group Limited was incorporated in 1922 and is headquartered in Docklands, Australia.
Stock Data
Price chart, volume, and trading data.
FRC Fair Value Algorithm
What the FRC Fair Value algorithm says it is worth vs. the current price — FRC's own, on every stock.
About this section
Fair value for Ebos Group Limited from FRC's valuation model, read against the market price. EBO.AX last traded at AUD 18.36, 16.7× trailing earnings — the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for Ebos Group Limited. Starting points for Ebos Group Limited: P/E 16.7, EPS AUD 1.07, beta 0.15 — an Medical - Distribution name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
About this section
Dividend history, yield and payout sustainability for Ebos Group Limited. Ebos Group Limited does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for Ebos Group Limited. Trailing twelve-month EPS for Ebos Group Limited stands at AUD 1.07. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Wall Street Analyst Estimates
Analysts' price targets, ratings, and revenue and EPS estimates.
Earnings per share estimates
| Per share | This quarterDec 2026 | Next quarterJun 2027 | This yearYear to Jun 2027 | Next yearYear to Jun 2028 |
|---|---|---|---|---|
| Average estimate | AUD 0.65 | AUD 0.73 | AUD 1.43 | AUD 1.62 |
| Lowest estimate | AUD 0.65 | AUD 0.73 | AUD 1.43 | AUD 1.54 |
| Highest estimate | AUD 0.65 | AUD 0.73 | AUD 1.44 | AUD 1.73 |
| Number of analysts | 1 | 1 | 4 | 4 |
| A year ago | AUD 0.68 | AUD 0.49 | AUD 1.04 | — |
| Growth vs a year ago | −3.6% | +49.8% | +37.6% | — |
Revenue estimates
| Total | This quarterDec 2026 | Next quarterJun 2027 | This yearYear to Jun 2027 | Next yearYear to Jun 2028 |
|---|---|---|---|---|
| Average estimate | AUD 8.40B | AUD 7.97B | AUD 17.00B | AUD 17.66B |
| Lowest estimate | AUD 8.40B | AUD 7.97B | AUD 16.76B | AUD 17.20B |
| Highest estimate | AUD 8.40B | AUD 7.97B | AUD 17.26B | AUD 18.02B |
| Number of analysts | 1 | 1 | 10 | 10 |
| A year ago | AUD 5.99B | AUD 6.35B | AUD 12.82B | — |
| Growth vs a year ago | +40.2% | +25.5% | +32.6% | — |
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for Ebos Group Limited. Ebos Group Limited has reported as a listed company since 2013. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
| Ticker | Type | Company | Sector | Exchange | Mkt cap |
|---|---|---|---|---|---|
| ARRJFArjo AB (publ) | Healthcare | OTC | $840.2M | ||
| BIMIBIMI International Medical Inc. | Healthcare | OTC | $1,156 | ||
| CAHCardinal Health, Inc. | Healthcare | NYSE | $63.1B | ||
| CORCencora, Inc. | Healthcare | NYSE | $64.7B | ||
| EBOSYEBOS Group Limited | Healthcare | OTC | $1.8B | ||
| ENMIDH Enchantment Inc. | Healthcare | OTC | $383,131 | ||
| EXHIExlites Holdings International, Inc. | Healthcare | OTC | $16.0M | ||
| GALNFGalenica AG | Healthcare | OTC | $5.8B | ||
| HIGRHi-Great Group Holding Company | Healthcare | OTC | $8.2M | ||
| HSICHenry Schein, Inc. | Healthcare | NASDAQ | $9.2B | ||
| IUSDFAS ONE Corporation | Healthcare | OTC | $1.7B | ||
| MAHLYMediPal Holdings Corporation | Healthcare | OTC | $4.2B | ||
| Ticker | Fund | Fund assets | % of the fund |
|---|---|---|---|
| VAS.AXVanguard Australian Shares Index ETF | $27.0B in assets | 0.02% | |
| IHD.AXiShares S&P/ASX Dividend Opportunities ESG Screened ETF | $401M in assets | 0.17% | |
| ISO.AXiShares S&P/ASX Small Ordinaries ETF | $120M in assets | 0.27% | |
| SSO.AXState Street SPDR S&P/ASX Small Ordinaries ETF | $24M in assets | 0.27% | |
Largest holders first, then the funds most concentrated in EBO.AX.
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for Ebos Group Limited. Coverage tracks Ebos Group Limited within Medical - Distribution (Healthcare). Press releases and market coverage, newest first.

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of Ebos Group Limited.